Genentech, Tercica, Insmed Settle Patent Suit
Biotechnology companies Genentech Inc. and Tercica Inc. settled their lawsuit against rival start-up Insmed Inc. on Wednesday, ending a three-year-long patent scrimmage over Iplex, a drug used to treat hormone deficiencies...To view the full article, register now.
Already a subscriber? Click here to view full article